Introduction
Neurodevelopmental Disorders (NDDs) comprise a spectrum of disorders that include Autism Spectrum Disorder (ASD), Attention Deficit/Hyperactivity Disorder (ADHD), Developmental Coordination Disorder (DCD, also called Dyspraxia), Developmental Language Disorder (DLD, also called Dysphasia and previously called Specific Language Impairment), Dyscalculia (also called Mathematical or Arithmetic Disability), Dyslexia (also called Reading Disability), Intellectual Disability (ID, also called cognitive disability, previously called mental retardation) and Tic Disorders (including Tourette Syndrome and chronic tic disorder). Some definitions of NDDs also include Foetal Alcohol Syndrome, although we have not included it.
The prevalence of NDDs varies globally; however, the burden associated with NDDs is considerable, yet arguably underestimated. This paper provides a comprehensive review of the literature on NDDs, including the scale of the effect, and posits that both missing diagnoses and mis-diagnosis as well as the general 'messiness' of NDDs considerably limits our understanding of this spectrum of disorders. We offer three recommendations to advance our knowledge of the burden of NDDs and shape the future research agenda to develop interventions, management plans and policies to address this burden. countries and are generally higher in the United States of America (USA) than in the United Kingdom (UK) ( Table 1) . Although it was historically considered that children 'grew out of' most NDDs excepting ASD and ID, there is now good evidence that the impact of NDDs is lifelong for many individuals. In ASD, it has controversially been claimed that 'optimal outcome' (i.e. no or sub-clinical ASD symptoms) may occur in 3-20% of individuals, dependent on symptom severity, age of diagnosis and age of treatment [1] . In any case, most if not all individuals will have persisting challenges to a greater or lesser degree throughout life. The majority of studies indicate ADHD also predominantly persists into late adolescence and adulthood, with persistence occurring in between 50% and 80% of cases [2] [3] [4] [5] [6] [7] . However, a few studies indicate much lower persistence of childhood ADHD and an independent cohort of young adult-onset ADHD [8, 9] . Approximately 70% of children with DCD continue to exhibit significant motor difficulties through adolescence and into adulthood [10] and around 73% of 5-year-old children with language impairments continue to have these impairments when aged 18-20 years [11] . Dyslexia and Dyscalculia show similarly high rates of persistence. Jacobson found that among Dyslexic children aged 8-9 years, 83% failed to achieve reading standards expected for their age and experience at age 15-16 years despite the majority of these pupils receiving remedial instruction [12] . Additionally, 85% of these children had persisting phonological deficits and 60 % had persisting decoding deficits at age 18-19 years [13] . Mussolin et al. found that adults aged 18-50 years who had been diagnosed with Dyscalculia as children were slower and more error-prone when completing a mathematics battery [14] . The persistence of Tic Disorders depends on the diagnosis: Provisional Tic Disorder (formerly Transient Tic Disorder) represents the bulk of childhood cases and is classified as a tic disorder that resolves within a year [ Abbreviations: ADHD, attention-deficit/hyperactivity disorder; ASD, autism spectrum disorder; CTD, chronic tic disorder; DCD, developmental coordination disorder; DLD, developmental language disorder; ID, intellectual disability; MLD, moderate learning difficulty; SLD, severe learning difficulty; TS, Tourette's Syndrome; UK, United Kingdom; USA, United States of America. a. As the prevalence of ASD has increased markedly in the last thirty years, only studies whose data was collected within the last 15 years are included in this estimate. b. No estimate of the prevalence of DCD using DSM diagnostic criteria has been made for the USA. However, 10.1 % of American children scored <5 th centile on the Movement Assessment Battery for Children, a test often used to determine Criterion A of a DSM-IV or -V diagnosis of DCD [248] . In contrast, an estimated 4.2-4.5 of UK children score this [27, 247] . c. The prevalence of DLD among UK 3-year-olds is estimated to be 0. 290, 323, [326] [327] [328] [329] [330] [331] [332] . y. [322] . z. [322, [333] [334] [335] . aa. [324] . ab. [336] . ac. [290, 337] . ad. [336, [338] [339] [340] . ae. There are no co-occurrence rate estimates for individuals with a primary diagnosis of Dyslexia or Dyscalculia and a secondary diagnosis of ID, likely because when these conditions co-occur the ID is usually diagnosed first and considered the primary diagnosis. af. [22, [311] [312] [313] . ag. [22, 290, 341] . ah. [338] [339] [340] . ai. [313] . aj. [267, 342, 343] . ak. [342] [343] [344] . al. [342, 344] . am. [342] . an. [342, 343] arguments about co-occurrence have been made regarding psychiatric disorders, resulting in the Research Domain Criteria (RDoC) project [33] . Although this project is creating a research classification system and not considering diagnostic criteria or pathways, it marks a paradigm shift by considering psychiatric disorders in terms of affected neurobiological and behavioural systems rather than traditional categories or diagnostic criteria.
Accumulation of Adversity
There is increasing evidence that many individuals with NDDs accumulate problems over time in a cascading and cumulative manner. Cairney et al. proposed the 'Environmental Stress Hypothesis' to explain the developmental cascade from childhood DCD to childhood internalising problems to adult clinical depression and anxiety [34] . Other NDDs also show very high rates of co-occurring and/or secondary health problems, particularly psychiatric conditions ( Epilepsy or seizures [196, 391] Dyslexia Anxiety disorders, mood disorders, schizophrenia [388] [389] [390] 392, 393] Epilepsy or seizures [196, 198] ID Anxiety disorders, eating disorders, mood disorders, personality disorders, schizophrenia, substance use disorders [394] [395] [396] [397] [398] [399] [400] [401] [402] Various, depending on aetiology of ID 
Familial Impact
The effects of an NDD 'ripple out', reaching beyond the affected individual. Most research into these 'ripple effects' has been focused on the families and, particularly, the parents of individuals with NDDs. 
Issues with Estimating the Burden of Disease
Having considered the scale of the effect NDDs have on affected individuals, their families, their communities and society as a whole, one can begin to calculate the burden of illness that NDDs represent. However, the literature is affected by several major issues which produce biases whose effects are difficult to predict. Thus, anyone attempting to compare the burden of NDDs, either between disorders, between countries and/or over time quickly ends up comparing not only apples to oranges but to a whole fruit bowl of inconsistency and inaccuracy. 
Transferability
Another major issue affecting our ability to calculate the burden of NDDs is geography. This is a limitation of all health economics studies: they are specific to a given country and its characteristics (income/development level, demographics, structure and funding of healthcare, etc.). However, geography has a particularly strong effect on NDD burden-of-illness studies. Partly, this is due to the marked differences noted in diagnosed prevalence between countries (Table 1) , which may themselves be driven by geographic differences in service provision and benefits of a diagnosis (see below). However, NDDs are expensive diseases to manage which have an economic impact on a wide variety of public sectors including education, supported housing and employment, criminal justice and loss of tax revenue due to unor underemployment. Thus, direct medical costs for NDDs may be lower in countries with a healthcare system based primarily on private healthcare and thus less incentive to pay for early medical interventions to offset long-term costs to the public purse. The USA provides an example of this: its private healthcare system has a history of denying timely, effective treatment to individuals with ASD, resulting in the introduction of state-mandated waiver programmes to enforce private insurance coverage [152] . Subsequently, measurable differences in service use and direct medical costs have been observed between mandate-eligible and ineligible children with ASD [153] . Similar differences in healthcare expenditure are likely to exist between countries with primarily public healthcare, such as the UK, and primarily private healthcare, such as the USA.
Missed diagnoses and mis-diagnoses
To ensure calculations of NDD burden are accurate, robust national estimates of prevalence are required. This requires not only consistent naming of a disorder and use of diagnostic criteria, but also that all individuals requiring support are diagnosed in an accurate and timely manner. However, NDDs are frequently under-diagnosed and this differentially affects various demographic groups. There is increasing recognition that ASD may be under-diagnosed in girls [154, 155] , in part because the female social landscape may camouflage their ASD [156] . However, ASD diagnoses are also missed or delayed in ethnic minorities [157, 158] , including Gypsy/Romani and Irish Traveller children [159] ; individuals living below the poverty line [157] ; and those with co-occurring ADHD [157] and/or with psychiatric conditions [160] . [170] , where there is financial or other gain to be made. It is also suspected that doctors sometimes exaggerate or invent symptoms (so-called 'upcoding') in order to gain support for their patients, for example if an individual has significant impairment and meets some criteria of several NDDs but does not pass the diagnostic thresholds for any individual NDD [171] . The introduction of ASD-specific state-mandated healthcare insurance waivers in the USA and other analogous initiatives elsewhere is likely to only exacerbate this by ensuring that those with ASD, but not necessarily those with other, similarly or more severely disabling conditions, receive support [172] . However, notably when considering burden-of-illness studies, under-diagnosis and misdiagnosis mean that both the prevalence estimates and service use inventories for NDDs may be inaccurate.
Health professionals' NDD literacy
A final notable issue affecting prevalence estimates of NDDs and thus burden-of-illness calculations is the low level of awareness among healthcare and education professionals and the general public. Without sufficient awareness, many diagnoses will be missed and thus prevalence estimates will be inaccurate. The rising global prevalence of ASD has been attributed in part to rising awareness [173, 174] . A similar pattern has been observed for ADHD [175, 176] . However, this does not necessarily extend to other NDDs. For example, only 29 % of Canadian, UK and USA family/general physicians and 23 % of teachers are familiar with DCD (Wilson, Neil, Kamps, & Babcock, 2013) whereas even within academic research Dyscalculia plays the poor relation of Dyslexia, which is far more widely recognised [178] . Awareness of NDDs both among professionals and the public is essential to ensure that people with NDDs get the help they need at the time when they need it.
A particular issue is a lack of awareness that NDDs often co-occur. This is true even within academic circles. Certain combinations of NDD are sometimes considered in research, such as ADHD and ASD [179, 180] or ADHD and DCD [181, 182] . However, studies in general and economic studies in particular rarely consider the co-occurrence of NDDs as a whole and nearly never consider cases where three or more NDDs are present. There is also a disconnect between the literature regarding social, attention and motor difficulties (ASD, ADHD, DCD) and the literature regarding learning difficulties (Dyscalculia, Dyslexia, ID) with very few studies investigating combinations of disorders spanning this divide. ASD research suffers especially in this respect as it has been the habit of researchers to consider associated symptoms such as motor, attention or learning deficits as just 'part of the syndrome' [161] or even a diagnostic feature [183, 184] rather than as co-occurring condition(s), an issue potentially driven by the historic exclusion of ADHD and/or DCD diagnoses in the case of ASD using DSM-IV criteria [147] . Within NDD research as a whole, there is often an obsession with identifying cohorts of 'pure' NDDs or restricting cohorts in other respects such as excluding those with low IQ or co-occurring psychiatric conditions. This occurs despite the fact that all evidence points to 'pure' disorders being in the minority (Table 2) . For example, a study of Canadian children with ADHD, DCD, Dyslexia, Conduct Disorder, Oppositional Defiant Disorder, anxiety and/or depression found that 52% of these children had two or more disorders and among those with ADHD this figure was 80% [22] . The artificial siloing of NDD research helps no one and means results are not representative of most individuals with NDDs.
Recognising the 'messiness' of NDDs
Ignoring the messy reality of NDDs means cohorts are often exceedingly unrepresentative of the population, rendering research at best limited and at worst flawed and potentially meaningless. Additionally, by failing to recognise the prevalence of co-occurrence ourselves, we make it even less likely that healthcare professionals, education professionals, governments and funding bodies will also recognise this. This has knock-on effects, both for patients and for economic analyses. If family/ general practitioners and teachers are unaware of the rates of co-occurrence, they are more likely to consider the patient with multiple NDDs as a hypochondriac or 'difficult'. However, the reality is that NDDs are associated with a dose-response of cumulative adversity: individuals with multiple co-occurring NDDs are in most need of support. Moreover, some combinations of NDDs and/or psychiatric conditions are associated with worse outcomes than others. 
What Must We do to Capture the True Burden of NDDs?
We have catalogued the major issues preventing us from capturing and comparing the true burden of NDDs. Rectifying these represents a significant challenge. However, three key recommendations can be made.
Firstly, the issue of co-occurrence needs to be confronted in order that services be targeted appropriately and the cost of these be accurately assessed. One model for this is ESSENCE [30] , which proposes that children aged less than three years presenting with any issues in general development, communication and language, social inter-relatedness, motor coordination, attention, activity, behaviour, mood and/or sleep not be compartmentalised off to 'ASD only', 'ADHD only', etc. centres. Instead, they should initially be assessed in a holistic manner for all ESSENCE symptoms in order to consider the overall impairment of the child and thus provide all necessary services in a timely manner. Subsequently, specialist/targeted (e.g. ASD-specific, ADHD-specific) support can be provided on the basis of need. A similar model is advocated by the POND Network [32] . Given the prevalence of co-occurrence among NDDs (Table 2 ) and the demonstrated importance of early treatment for example for ASD [187] or ADHD [188] , these seem eminently sensible suggestions. Indeed, we would take it further and suggest that the ESSENCE/POND model should be followed irrespective of age at initial diagnosis and that, particularly among individuals whose diagnosis was delayed until adulthood, assessment for psychiatric conditions should also be automatically considered.
Secondly, we need to address the issue of under-diagnosis of NDDs in certain sociodemographic groups. This is necessary to generate accurate prevalence estimates on which to base burden-of-illness calculations but also in order to improve equity in service delivery. We do not endorse the wholesale screening of all children. However, there is an argument for the targeted use of routine screening following the ESSENCE/POND model within at-risk populations. These populations include those known to be more likely to have NDDs such as looked-after and adopted children [189] , children excluded from school [190] and prison populations [49, 191] . It may also be beneficial to target populations with certain medical conditions based on their known co-occurrence with NDDs (Table 4 ). An example is Rolandic epilepsy (also known as Benign Childhood Epilepsy with Centrotemporal Spikes (BECCTS)), which frequently cooccurs with ADHD [192, 193] , DLD [194] , DCD [195] , Dyscalculia [196, 197] and Dyslexia [198] . In addition, given the heritable nature of NDDs, screening should be considered where there is a strong family history of NDDs.
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However, routine screening and increased professional awareness is only part of the process. We as a society need to ensure that diagnosis is a worthwhile process that results in benefits that outweigh the downsides such as stigma [199] or the fear that a 'label' may become a self-fulfilling prophecy [200] . Unless this is done, individuals and/or their families may opt out of gaining a diagnosis [200] as they fear over-diagnosis, i.e. correct diagnosis that nonetheless does not benefit the individual as it comes with stigma and/or little or no medical or educational assistance [201] . This is a valid fear. For example, among American adolescents and young adults with Asperger's Syndrome, symptom severity is inversely associated with risk of victimization [202] .
Thirdly, we need to base burden-of-illness studies on all aspects of NDDs not just the direct medical costs paid by public or private healthcare insurance. This is a particular issue with NDDs as many of the costs are borne by other public services such as education, supported housing, training and employment. Other costs of NDDs are also hidden, for example under the costs of co-occurring, potentially secondary, psychiatric conditions (Table  3 ) or the costs of unemployment, homelessness or being in the criminal justice system. There is a clear need for society to invest in early diagnosis and timely provision of appropriate medical and educational services for individuals with NDDs in order to minimise the economic and psychosocial burden of these hidden costs. Until robust burden-of-illness calculations are carried out for NDDs that consider all aspects of economic impact, we cannot conduct comprehensive economic evaluations that accurately reflect the population. Without these, we will be unable to ensure that individuals with NDDs receive the best care possible in a timely manner.
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